Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Linu Jacob"'
Publikováno v:
South Asian Journal of Cancer, Vol 13, Iss 02, Pp 090-098 (2024)
Externí odkaz:
https://doaj.org/article/cb453e4a45aa4f1f8e0de9dd9ffde76e
Autor:
Tanvir Pasha, Uday Krishna, Rahul Loni, Anil Kumar, Varatharaj Chandraraj, Purushottam Chavan, Ashok Shenoy, Linu Jacob, Thimmaiah Naveen, Lokesh Vishwanath
Publikováno v:
Middle East Journal of Cancer, Vol 13, Iss 4, Pp 665-673 (2022)
Background: Long-term outcomes of intensity modulated radiotherapy with reduced high-risk clinical target volume (HRCTV) margin for radical chemoradiation of locally advanced head and neck cancers (LAHNSCC).Method: The present retrospective study inv
Externí odkaz:
https://doaj.org/article/451dd008723f4665a949fc3ea6e26a32
Autor:
Rudresha Antapura Haleshappa, Aditi Harsh Thanky, Lakshmaiah Kuntegowdanahalli, Govind Babu Kanakasetty, Lokanatha Dasappa, Linu Jacob
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 3, Pp 122-124 (2017)
Context: Nasopharyngeal carcinoma (NPC) is a rare head and neck cancer with significant geographical variation. There are limited data on epidemiology and outcomes of NPC reported from Southern India. Settings and Design: Retrospective analysis. Mate
Externí odkaz:
https://doaj.org/article/6752b24e7aee480ebd6ffa0dab2845b1
Autor:
K C Lakshmaiah, T M Suresh, K Govind Babu, Nagesh T Sirsath, Lokanatha Dasappa, Linu Jacob Abraham
Publikováno v:
South Asian Journal of Cancer, Vol 4, Iss 2, Pp 61-64 (2015)
Background: Oral cavity cancer is a significant health problem in India. Majority of patients present with locally advanced disease requiring multimodality treatment. Compliance to recommended treatment is an important factor affecting outcome. Aims:
Externí odkaz:
https://doaj.org/article/8011529eb4424b6c827c490ebc689a8d
Autor:
Rohan Bhise, Samit Purohit, Lokanatha D, Linu Jacob, Suresh TM, Govind Babu K, Suresh Babu, Lakshmaiah KC
Publikováno v:
Online Journal of Health & Allied Sciences, Vol 11, Iss 4 (2013)
Objective: To evaluate the efficacy of imatinib in chronic myeloid leukemia patients with variant translocations. Methods: Forty eight chronic myeloid leukemia patients carrying variant translocations and treated with imatinib at our institute were c
Externí odkaz:
https://doaj.org/article/2d0813ae728b46ff98c51d1327f0c0d4
Publikováno v:
South Asian Journal of Cancer, Vol , Iss
Externí odkaz:
https://doaj.org/article/1d787691c5044f2288a5a2aa7aee13a4
Autor:
Akkamahadevi Patil, Sharada Patil, CE Anupama, Savitha Rajarajan, Vidya Prasad Nimbalkar, Usha Amirtham, G Champaka, MN Suma, Geetha V Patil, Ashwini Nargund, VR Pallavi, Linu Jacob, CS Premalatha, Jyothi S Prabhu
In high grade serous ovarian cancers (HG-SOC), BRCA1/2 mutations have been reported as the most predominant mutations by various studies. However, the non-mutational mechanisms of BRCA pathway inactivation in HG-SOC are unclear. We aimed to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da767f8b1e411bec1fb48b74679c9b9
https://doi.org/10.2139/ssrn.4348183
https://doi.org/10.2139/ssrn.4348183
Autor:
Ankit Agarwal, K Govind Babu, M C Suresh Babu, L K Rajeev, K C Lakshmaiah, A H Rudresha, Linu Jacob Abraham, K N Lokesh, D Loknatha
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 40:406-408
Background: Tumor lysis syndrome (TLS) is an oncological emergency associated with life-threatening metabolic abnormalities. Hyperuricemia is a feature of TLS and is treated with hydration, urine alkalinization, and allopurinol. Rasburicase lowers ur
Autor:
Linu, Jacob Abraham1, Udupa, M. S. Namratha1 msn.udupa@gmail.com, Madhumathi, D. S.1, Lakshmaiah, K. C.1, Babu, K. Govind1, Lokanatha, D.1, Babu, M. C. Suresh1, Lokesh, K. N.1, Rajeev, L. K.1, Rudresha, A. H.1
Publikováno v:
Ecancermedicalscience. 2017, Vol. 11 Issue 709-727, p1-9. 9p.
Autor:
Abraham, Linu Jacob1, Saldanha, Smitha Carol1 saldanhasmitha@gmail.com, Kuntegowdanahalli, Lakshmaiah Chinnagiriyappa1, Bharatnur, Shankaranand2, Dasappa, Lokanatha1, Babu, Govind1, Babu, Mallekavu Suresh1, Kiran, Pretesh Rohan3
Publikováno v:
Clinical Cancer Investigation Journal. Mar/Apr2016, Vol. 5 Issue 2, p141-145. 5p.